Tags

Type your tag names separated by a space and hit enter

Brain amyloid imaging--FDA approval of florbetapir F18 injection.
N Engl J Med. 2012 Sep 06; 367(10):885-7.NEJM

Authors+Show Affiliations

Division of Medical Imaging Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

22931256

Citation

Yang, Lucie, et al. "Brain Amyloid imaging--FDA Approval of Florbetapir F18 Injection." The New England Journal of Medicine, vol. 367, no. 10, 2012, pp. 885-7.
Yang L, Rieves D, Ganley C. Brain amyloid imaging--FDA approval of florbetapir F18 injection. N Engl J Med. 2012;367(10):885-7.
Yang, L., Rieves, D., & Ganley, C. (2012). Brain amyloid imaging--FDA approval of florbetapir F18 injection. The New England Journal of Medicine, 367(10), 885-7. https://doi.org/10.1056/NEJMp1208061
Yang L, Rieves D, Ganley C. Brain Amyloid imaging--FDA Approval of Florbetapir F18 Injection. N Engl J Med. 2012 Sep 6;367(10):885-7. PubMed PMID: 22931256.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Brain amyloid imaging--FDA approval of florbetapir F18 injection. AU - Yang,Lucie, AU - Rieves,Dwaine, AU - Ganley,Charles, PY - 2012/8/31/entrez PY - 2012/8/31/pubmed PY - 2012/9/15/medline SP - 885 EP - 7 JF - The New England journal of medicine JO - N Engl J Med VL - 367 IS - 10 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/22931256/Brain_amyloid_imaging__FDA_approval_of_florbetapir_F18_injection_ L2 - https://www.nejm.org/doi/10.1056/NEJMp1208061?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -